IVL for Stent Underexpantsion

CompletedOBSERVATIONAL
Enrollment

62

Participants

Timeline

Start Date

November 1, 2019

Primary Completion Date

April 1, 2021

Study Completion Date

April 1, 2021

Conditions
In Stent RestenosisCoronary Artery CalcificationIntravascular Lithotripsy
Interventions
DEVICE

Percutaneous Coronary Intervention

Intravascular lithotripsy (IVL)

Trial Locations (16)

Unknown

Department of Invasive Cardiology, Medical University of Bialystok, The Medical University of Bialystok Clinical Hospital, Bialystok

First Department of Cardiology, Medical University of Gdansk, Gdansk

Second Department of Cardiology, Jagiellonian University Medical College, Krakow, Poland, Krakow

Miedziowe Centrum Zdrowia S.A., Lubin

Department of Cardiology, University Hospital, Institute of Medical Sciences, Opole

Department of Cardiology, Poznan University of Medical Sciences, Poznan

Department of Cardiology, Poznan

Department of Cardiology, The Ministry of Internal Affairs and Administration Hospital, Rzeszow, Rzeszów

1st Department of Cardiology, Medical University of Warsaw, Warsaw

Department of Cardiology and Internal Diseases, Military Institute of Medicine, Warsaw

Department of Interventional Cardiology and Angiology, National Institute of Cardiology, Warsaw, Poland, Warsaw

Department of Invasive Cardiology, Centre of Postgraduate Medical Education, Central Clinical Hospital of the Ministry of Interior and Administration, Warsaw

Department of Invasive Cardiology, Wejherowo, Wejherowo

Centre for Heart Disease, University Hospital Wroclaw Department of Heart Disease, Wroclaw Medical University, Wroclaw

Third Department of Cardiology, Medical University of Katowice, Zabrze

40-635

Department of Cardiology and Structural Heart Diseases, Medical University of Silesia, Katowice, Poland, Katowice

All Listed Sponsors
collaborator

Wojciech Wojakowski

UNKNOWN

lead

Medical University of Silesia

OTHER

NCT05112250 - IVL for Stent Underexpantsion | Biotech Hunter | Biotech Hunter